Specific changes of sulfatide levels in individuals with pre-clinical Alzheimer's disease

An early event in disease pathogenesis

Hua Cheng, Miao Wang, Jian Liang Li, Nigel J. Cairns, Xianlin Han

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

To explore the hypothesis that alterations in cellular membrane lipids are present at the stage of pre-clinical Alzheimer's disease (AD) (i.e., cognitively normal at death, but with AD neuropathology), we performed targeted shotgun lipidomics of lipid extracts from post-mortem brains of subjects with pre-clinical AD. We found sulfatide levels were significantly lower in subjects with pre-clinical AD compared to those without AD neuropathology. We also found that the level of ethanolamine glycerophospholipid was marginally lower at this stage of AD, whereas changes of the ceramide levels were undetectable with the available samples. These results indicate that cellular membrane defects are present at the earliest stages of AD pathogenesis and also suggest that sulfatide loss is among the earliest events of AD development, while alterations in the levels of ethanolamine glycerophospholipid and ceramide occur relatively later in disease. To determine lipid changes at the stage of pre-clinical Alzheimer's disease (AD) (i.e., cognitively normal at death, but with AD neuropathology), we performed lipidomics analysis and found that sulfatide levels were significantly lower in subjects with pre-clinical AD compared to those without AD neuropathology. The results suggest that sulfatide loss is among the earliest events of AD development.

Original languageEnglish (US)
Pages (from-to)733-738
Number of pages6
JournalJournal of Neurochemistry
Volume127
Issue number6
DOIs
StatePublished - Dec 1 2013
Externally publishedYes

Fingerprint

Sulfoglycosphingolipids
Alzheimer Disease
Glycerophospholipids
Ethanolamine
Ceramides
Lipids
Firearms
Membrane Lipids

Keywords

  • ceramide
  • membrane lipids
  • plasmalogen
  • pre-clinical Alzheimer's disease
  • shotgun lipidomics
  • sulfatide

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Specific changes of sulfatide levels in individuals with pre-clinical Alzheimer's disease : An early event in disease pathogenesis. / Cheng, Hua; Wang, Miao; Li, Jian Liang; Cairns, Nigel J.; Han, Xianlin.

In: Journal of Neurochemistry, Vol. 127, No. 6, 01.12.2013, p. 733-738.

Research output: Contribution to journalArticle

@article{f302c2ff2af34c378569a92499a2e620,
title = "Specific changes of sulfatide levels in individuals with pre-clinical Alzheimer's disease: An early event in disease pathogenesis",
abstract = "To explore the hypothesis that alterations in cellular membrane lipids are present at the stage of pre-clinical Alzheimer's disease (AD) (i.e., cognitively normal at death, but with AD neuropathology), we performed targeted shotgun lipidomics of lipid extracts from post-mortem brains of subjects with pre-clinical AD. We found sulfatide levels were significantly lower in subjects with pre-clinical AD compared to those without AD neuropathology. We also found that the level of ethanolamine glycerophospholipid was marginally lower at this stage of AD, whereas changes of the ceramide levels were undetectable with the available samples. These results indicate that cellular membrane defects are present at the earliest stages of AD pathogenesis and also suggest that sulfatide loss is among the earliest events of AD development, while alterations in the levels of ethanolamine glycerophospholipid and ceramide occur relatively later in disease. To determine lipid changes at the stage of pre-clinical Alzheimer's disease (AD) (i.e., cognitively normal at death, but with AD neuropathology), we performed lipidomics analysis and found that sulfatide levels were significantly lower in subjects with pre-clinical AD compared to those without AD neuropathology. The results suggest that sulfatide loss is among the earliest events of AD development.",
keywords = "ceramide, membrane lipids, plasmalogen, pre-clinical Alzheimer's disease, shotgun lipidomics, sulfatide",
author = "Hua Cheng and Miao Wang and Li, {Jian Liang} and Cairns, {Nigel J.} and Xianlin Han",
year = "2013",
month = "12",
day = "1",
doi = "10.1111/jnc.12368",
language = "English (US)",
volume = "127",
pages = "733--738",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Specific changes of sulfatide levels in individuals with pre-clinical Alzheimer's disease

T2 - An early event in disease pathogenesis

AU - Cheng, Hua

AU - Wang, Miao

AU - Li, Jian Liang

AU - Cairns, Nigel J.

AU - Han, Xianlin

PY - 2013/12/1

Y1 - 2013/12/1

N2 - To explore the hypothesis that alterations in cellular membrane lipids are present at the stage of pre-clinical Alzheimer's disease (AD) (i.e., cognitively normal at death, but with AD neuropathology), we performed targeted shotgun lipidomics of lipid extracts from post-mortem brains of subjects with pre-clinical AD. We found sulfatide levels were significantly lower in subjects with pre-clinical AD compared to those without AD neuropathology. We also found that the level of ethanolamine glycerophospholipid was marginally lower at this stage of AD, whereas changes of the ceramide levels were undetectable with the available samples. These results indicate that cellular membrane defects are present at the earliest stages of AD pathogenesis and also suggest that sulfatide loss is among the earliest events of AD development, while alterations in the levels of ethanolamine glycerophospholipid and ceramide occur relatively later in disease. To determine lipid changes at the stage of pre-clinical Alzheimer's disease (AD) (i.e., cognitively normal at death, but with AD neuropathology), we performed lipidomics analysis and found that sulfatide levels were significantly lower in subjects with pre-clinical AD compared to those without AD neuropathology. The results suggest that sulfatide loss is among the earliest events of AD development.

AB - To explore the hypothesis that alterations in cellular membrane lipids are present at the stage of pre-clinical Alzheimer's disease (AD) (i.e., cognitively normal at death, but with AD neuropathology), we performed targeted shotgun lipidomics of lipid extracts from post-mortem brains of subjects with pre-clinical AD. We found sulfatide levels were significantly lower in subjects with pre-clinical AD compared to those without AD neuropathology. We also found that the level of ethanolamine glycerophospholipid was marginally lower at this stage of AD, whereas changes of the ceramide levels were undetectable with the available samples. These results indicate that cellular membrane defects are present at the earliest stages of AD pathogenesis and also suggest that sulfatide loss is among the earliest events of AD development, while alterations in the levels of ethanolamine glycerophospholipid and ceramide occur relatively later in disease. To determine lipid changes at the stage of pre-clinical Alzheimer's disease (AD) (i.e., cognitively normal at death, but with AD neuropathology), we performed lipidomics analysis and found that sulfatide levels were significantly lower in subjects with pre-clinical AD compared to those without AD neuropathology. The results suggest that sulfatide loss is among the earliest events of AD development.

KW - ceramide

KW - membrane lipids

KW - plasmalogen

KW - pre-clinical Alzheimer's disease

KW - shotgun lipidomics

KW - sulfatide

UR - http://www.scopus.com/inward/record.url?scp=84890115095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890115095&partnerID=8YFLogxK

U2 - 10.1111/jnc.12368

DO - 10.1111/jnc.12368

M3 - Article

VL - 127

SP - 733

EP - 738

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 6

ER -